Feddema W[au] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2007	1
2008	1
2009	2
2023	0

Page 1

Multidrug resistance proteins 2 and 3 provide alternative routes for hepatic excretion of morphine-glucuronides.

van de Wetering K, Zelcer N, Kuil A, Feddema W, Hillebrand M, Vlaming ML, Schinkel AH, Beijnen JH, Borst P. van de Wetering K, et al. Among authors: feddema w. Mol Pharmacol. 2007 Aug;72(2):387-94. doi: 10.1124/mol.107.035592. Epub 2007 May 7. Mol Pharmacol. 2007. PMID: 17485564

Targeted metabolomics identifies glucuronides of dietary phytoestrogens as a major class of MRP3 substrates in vivo.

van de Wetering K, Feddema W, Helms JB, Brouwers JF, Borst P. van de Wetering K, et al. Among authors: feddema w. Gastroenterology. 2009 Nov;137(5):1725-35. doi: 10.1053/j.gastro.2009.06.052. Epub 2009 Jul 3. Gastroenterology. 2009. PMID: 19577570

Intestinal breast cancer resistance protein (BCRP)/Bcrp1 and multidrug resistance protein 3 (MRP3)/Mrp3 are involved in the pharmacokinetics of resveratrol.

van de Wetering K, Burkon A, Feddema W, Bot A, de Jonge H, Somoza V, Borst P. van de Wetering K, et al. Among authors: feddema w. Mol Pharmacol. 2009 Apr;75(4):876-85. doi: 10.1124/mol.108.052019. Epub 2008 Dec 29. Mol Pharmacol. 2009. PMID: 19114588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

3 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year